Published in J Org Chem on October 15, 2004
(E)-1-(2,4-Dichloro-phen-yl)-3-(1,3-diphenyl-1H-pyrazol-4-yl)prop-2-en-1-one. Acta Crystallogr Sect E Struct Rep Online (2011) 1.50
(2E)-3-(1,3-Diphenyl-1H-pyrazol-4-yl)-1-phenyl-prop-2-en-1-one. Acta Crystallogr Sect E Struct Rep Online (2011) 0.83
Microbiological Evaluation of 4-substituted-imidazolidine Derivatives. Indian J Pharm Sci (2012) 0.78
Crystal structure of N'-di-phenyl-methyl-idene-5-methyl-1H-pyrazole-3-carbo-hydrazide. Acta Crystallogr E Crystallogr Commun (2015) 0.75
N'-Benzoyl-5-methyl-1,3-diphenyl-1H-pyrazole-4-carbohydrazide. Acta Crystallogr Sect E Struct Rep Online (2013) 0.75
Synthesis, molecular properties, toxicity and biological evaluation of some new substituted imidazolidine derivatives in search of potent anti-inflammatory agents. Saudi Pharm J (2015) 0.75
An introductory characterization of a combat-casualty-care relevant swine model of closed head injury resulting from exposure to explosive blast. J Neurotrauma (2009) 1.86
Preclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers. Clin Cancer Res (2006) 1.02
Structure-activity relationship of triazafluorenone derivatives as potent and selective mGluR1 antagonists. J Med Chem (2005) 0.91
Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction. J Med Chem (2006) 0.88
Correlation between brain/plasma ratios and efficacy in neuropathic pain models of selective metabotropic glutamate receptor 1 antagonists. Bioorg Med Chem Lett (2006) 0.85
Effects of selective dopamine receptor subtype agonists on cardiac contractility and regional haemodynamics in rats. Clin Exp Pharmacol Physiol (2004) 0.84
Warfare-related craniectomy defect reconstruction: early success using custom alloplast implants. Plast Reconstr Surg (2011) 0.84
1-aryl-3-(4-pyridine-2-ylpiperazin-1-yl)propan-1-one oximes as potent dopamine D4 receptor agonists for the treatment of erectile dysfunction. J Med Chem (2006) 0.81
An efficient multigram synthesis of the potent histamine H3 antagonist GT-2331 and the reassessment of the absolute configuration. J Org Chem (2004) 0.80
Multimodal monitoring during emergency hemicraniectomy for vein of Labbe thrombosis. Neurocrit Care (2006) 0.79
An efficient, stereoselective synthesis of the hydroxyethylene dipeptide isostere core for the HIV protease inhibitor A-792611. J Org Chem (2006) 0.79
Long-term outcomes of combat casualties sustaining penetrating traumatic brain injury. J Trauma Acute Care Surg (2012) 0.79
ABT-963 [2-(3,4-difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)-5-(4-methanesulfonyl-phenyl)-2H-pyridazin-3-one], a highly potent and selective disubstituted pyridazinone cyclooxgenase-2 inhibitor. J Pharmacol Exp Ther (2004) 0.78
Synthesis and structure-activity studies on N-[5-(1H-imidazol-4-yl)-5,6,7,8-tetrahydro-1-naphthalenyl]methanesulfonamide, an imidazole-containing alpha(1A)-adrenoceptor agonist. J Med Chem (2004) 0.78
Cerebral hemodynamic changes after wartime traumatic brain injury. Acta Neurochir Suppl (2013) 0.78